发明名称 |
CRYSTALLINE FORMS OF ALKOXYIMIDAZOL-1-YLMETHYL BIPHENYL CARBOXYLIC ACID |
摘要 |
PROBLEM TO BE SOLVED: To provide novel crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid, which has angiotensin II type 1 receptor antagonist activity and neprilysin-inhibition activity and is used for treating hypertension or heart failure.SOLUTION: The invention provides crystalline heminapadisylate salt or oxalate salt of 4'-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]-imidazol-1-ylmethyl}-3'-fluorobiphenyl-2-carboxylic acid represented by formula (I) characterized by a powder x-ray diffraction pattern comprising specific diffraction peaks.SELECTED DRAWING: None |
申请公布号 |
JP2016028061(A) |
申请公布日期 |
2016.02.25 |
申请号 |
JP20150174397 |
申请日期 |
2015.09.04 |
申请人 |
THERAVANCE BIOPHARMA R&D IP LLC |
发明人 |
ポール アール. ファザリー;ヴァンキャット アール. サラディー |
分类号 |
C07D233/70;A61K31/4174;A61K45/00;A61P9/04;A61P9/12;A61P43/00;C07C51/41;C07C55/07;C07C303/32;C07C309/05;C07C309/34 |
主分类号 |
C07D233/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|